Centre Hospitalier Henri Laborit
Poitiers, France
Location status: Recruiting
Location contact
Ghina Harika-Germaneau, MD, PhD
CONTACT
NCT Number: NCT04956016
The main objective is to demonstrate that dTMS is more efficient than high frequency rTMS with a conventional coil.
The patient will receive treatment arm A or B :
Arm A : classic rTMS treatment (use of the 8-shaped coil) and standard therapy Arm B: treatment with deep rTMS (use of the H-shaped coil (helmet)) and standard therapies.
20 rTMS sessions are planned (5 sessions per week) and 3 follow-up visits : at Day 30, Day 60 and Day 90.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Poitiers, France
Location status: Recruiting
Ghina Harika-Germaneau, MD, PhD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
20 rTMS sessions are planned (5 sessions per week)
20 rTMS sessions are planned (5 sessions per week)
Time frame: Day 60
The main objective is to demonstrate that dTMS is more efficient than high frequency rTMS with a conventional coil.
Modification of the MADRS score compared to baseline score. MADRS stands for Montgomery-Asberg Depression Rating Scale. It is used to measure the severity of depressive episodes in patients with mood disorders. The questionnaire includes questions on the following symptoms 1. Apparent sadness 2. Reported sadness 3. Inner tension 4. Reduced sleep 5. Reduced appetite 6. Concentration difficulties 7. Lassitude 8. Inability to feel 9. Pessimistic thoughts 10. Suicidal thoughts and each item yields a score of 0 to 6. The overall score ranges from 0 to 60. A score from 0 to 6 being normal/symptom absent and a score >34 being severe depression.
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Henri Laborit
Other
Open-label Randomized Comparative Study of the Effects of a Classic High-frequency rTMS Treatment Versus a Deep rTMS Treatment in the Management of Resistant Depression
Acronym: HAUVERDEEP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07284667
Depressive Disorder, Depressive Disorder, Major
Birmingham, Alabama, United States
View Trial DetailsNCT06511908
Behavior, Behavioral Symptoms
Bethesda, Maryland, United States
View Trial DetailsNCT07053345
Depressive Disorder, Depressive Disorder, Treatment-Resistant
Goyang Si Gyeonggi Do, South Korea
View Trial DetailsNCT02994433
Depressive Disorder, Depressive Disorder, Major
St Louis, Missouri, United States
View Trial Details